Self-Monitoring of Blood Pressure With Mobile App Feedback Enhances Control and Adherence in Uncontrolled Hypertension: Insights From the SMART-BP Trial and Broader Evidence
The SMART-BP randomized trial confirmed that a mobile app incorporating tailored feedback significantly lowers home systolic blood pressure and improves medication adherence compared with self-monitoring alone.
Systematic reviews and meta-analyses reaffirm the efficacy of home blood pressure monitoring (HBPM) in diagnosing and managing hypertension, enhancing patient compliance, and potentially reducing healthcare costs.
Pharmacologic advances, including sacubitril/valsartan and combination therapies, demonstrate improved blood pressure control and safety profiles in diverse hypertensive populations.
Despite high hypertension prevalence worldwide, control rates remain suboptimal, emphasizing the need for multifaceted approaches integrating technological, pharmacological, and public health strategies.
